Trial Profile
BCG vaccination to Reduce the impact of COVID-19 in healthcare workers following Coronavirus Exposure (BRACE) Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Sep 2023
Price :
$35
*
At a glance
- Drugs BCG vaccine (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Acronyms BRACE
- 27 Apr 2023 Results (n=3988) published in the New England Journal of Medicine
- 12 Jul 2022 Status changed from active, no longer recruiting to completed.
- 26 Apr 2022 Planned End Date changed from 30 Mar 2022 to 12 May 2022.